AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 3

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.05 % area, n=619. Read the 2025-Q2 state-of-the-index report →

619 records16 pagesmedian on this page 99.10 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020093TirzepatideSWBSWB-2505-R8575Janoshik2025-Q299.092.54102.2Buyer-sourced1MARGINAL
AX-2025-021069HexarelinBCHBCH-2501-B4807PeptideMeter2025-Q297.695.9891.4Buyer-sourced0FAIL
AX-2025-020854IpamorelinCPCCPC-2502-D1911Janoshik2025-Q299.164.5991.5Buyer-sourced1MARGINAL
AX-2025-020087TirzepatideSWBSWB-2505-R8575Janoshik2025-Q299.202.7496.0Buyer-sourced1MARGINAL
AX-2025-021104RetatrutideBCHBCH-2412-Y5177PeptideMeter2025-Q296.813.75104.5Buyer-sourced0PASS
AX-2025-021204TirzepatidePPGPPG-2503-R7317Janoshik2025-Q299.025.12—Laboratory-retained1MARGINAL
AX-2025-021062TirzepatideBCHBCH-2501-D4197Medutest2025-Q297.494.70—Supplier-supplied2FAIL
AX-2025-021057TirzepatideBCHBCH-2501-D4197PeptideMeter2025-Q297.354.72—Buyer-sourced1FAIL
AX-2025-020985ARA-290WXTWXT-2502-N3730Janoshik2025-Q299.134.26—Buyer-sourced1MARGINAL
AX-2025-020859TB-500CPCCPC-2411-X1899Janoshik2025-Q299.582.3295.7Buyer-sourced3FAIL
AX-2025-020625MK-677 (Ibutamoren mesylate)GL BiochemGLBI-2501-Y7989Kestrel2025-Q299.204.8893.2Buyer-sourced1FAIL
AX-2025-0195105-Amino-1MQJEEPJEEP-2412-M9286PeptideMeter2025-Q299.936.04—Buyer-sourced0FAIL
AX-2025-019426L-Glutathione (reduced)HYBHYB-2502-S7614Nordanalyt2025-Q299.358.00—Buyer-sourced0PASS
AX-2025-018783GHRP-6FGPFGP-2411-J8288PeptideMeter2025-Q299.875.6995.3Buyer-sourced0PASS
AX-2025-020863MK-677 (Ibutamoren mesylate)CPCCPC-2503-G2382Janoshik2025-Q298.535.5497.5Buyer-sourced1FAIL
AX-2025-020325BPC-157GGPepsGGPE-2411-V3137Janoshik2025-Q298.573.25—Buyer-sourced0PASS
AX-2025-019885MK-677 (Ibutamoren mesylate)HJHJ-2501-G5680PeptideMeter2025-Q299.735.3998.8Supplier-supplied0FAIL
AX-2025-019526EpitalonJEEPJEEP-2502-J8739Kestrel2025-Q299.739.25—Buyer-sourced0FAIL
AX-2025-019115RetatrutideGSPGSP-2411-B2857PeptideMeter2025-Q297.497.38—Buyer-sourced0PASS
AX-2025-018929TirzepatideTFSTFS-{CAT}-9918Janoshik2025-Q296.845.52103.0Buyer-sourced1FAIL
AX-2025-018910CJC-1295 with DACTFSTFS-{CAT}-1220Janoshik2025-Q298.604.2696.7Buyer-sourced1MARGINAL
AX-2025-018815ExenatideFGPFGP-2504-V8032Janoshik2025-Q298.684.5493.7Buyer-sourced0PASS
AX-2025-019783GHRP-6HomopeptideHOMO-2504-G4514Janoshik2025-Q299.703.72—Buyer-sourced0PASS
AX-2025-019206TirzepatideSinoPepSNP-2502-X4903PeptideMeter2025-Q298.516.80100.5Buyer-sourced0PASS
AX-2025-019072AOD-9604GSPGSP-2411-L2462Janoshik2025-Q298.794.9898.6Buyer-sourced0PASS
AX-2025-018969SelankASYASY-{CAT}-1298VendorInvestigate2025-Q299.839.6999.4Buyer-sourced0PASS
AX-2025-018914CJC-1295 with DACTFSTFS-{CAT}-1220Janoshik2025-Q298.874.81103.0Buyer-sourced1MARGINAL
AX-2025-020053RetatrutideSWBSWB-2503-P7565Kestrel2025-Q298.654.9989.6Buyer-sourced2MARGINAL
AX-2025-019949SemaglutideHJHJ-2504-Y7274Nordanalyt2025-Q298.944.88—Buyer-sourced1MARGINAL
AX-2025-019947SemaglutideHJHJ-2504-Y7274Janoshik2025-Q298.674.4290.7Buyer-sourced1MARGINAL
AX-2025-019699ARA-290TFCTFC-2501-K2935Janoshik2025-Q299.915.4792.3Buyer-sourced0PASS
AX-2025-019500TirzepatideJEEPJEEP-2412-U8403Medutest2025-Q299.422.4389.7Buyer-sourced1MARGINAL
AX-2025-019184BPC-157SinoPepSNP-2501-E3910Nordanalyt2025-Q299.114.42—Buyer-sourced0PASS
AX-2025-019049Thymosin α1ASYASY-{CAT}-2031Janoshik2025-Q299.394.0598.5Buyer-sourced0PASS
AX-2025-018601N-Acetyl Semax AmideQYBQYB-2501-C5179Janoshik2025-Q299.505.9297.0Laboratory-retained0PASS
AX-2025-021080MOTS-cBCHBCH-2505-J4599Medutest2025-Q298.812.6691.9Supplier-supplied0PASS
AX-2025-020964TirzepatideWXTWXT-2411-F3188Janoshik2025-Q298.484.83—Buyer-sourced0PASS
AX-2025-020700CJC-1295 (no DAC)SGNSGN-2412-L9210Nordanalyt2025-Q299.364.3791.3Buyer-sourced0PASS
AX-2025-019521GHRP-6JEEPJEEP-2503-B8635PeptideMeter2025-Q299.335.1892.1Buyer-sourced0PASS
AX-2025-0195125-Amino-1MQJEEPJEEP-2412-M9286Medutest2025-Q299.935.62104.7Buyer-sourced1FAIL